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A model for Niemann–Pick type C disease in the nematode
Caenorhabditis elegans
Mary Sym*, Michael Basson and Carl Johnson
Niemann–Pick type C (NP-C) disease is a progressive
neurodegenerative disorder characterized by the
inappropriate accumulation of unesterified cholesterol
in lysosomes [1]. NP-C patients show various defects
including hepatosplenomegaly, ataxia, dystonia and
dementia. Most cases of NP-C are associated with
inactivating mutations of the NPC1 gene [2], which
encodes a protein implicated in the retrograde transport
of sterols and other cargo from lysosomes [3].
Furthermore, localization of the NPC1 protein to
lysosomal/endosomal compartments is essential for
proper transport [4]. To create a model of NP-C disease
in a simple, genetically tractable organism, we generated
deletion mutations in two Caenorhabditis elegans
homologs of the human NPC1 gene, designated npc-1
and npc-2. Animals mutant for npc-1 developed slowly,
laid eggs prematurely, and were hypersensitive to
cholesterol deprivation. Furthermore, npc-1; npc-2
double-mutant animals inappropriately formed dauer
larvae under favorable growth conditions. These
phenotypes in C. elegans provide a model system for
both genetic and chemical suppressor screening that
could identify promising drug targets and leads for
NP-C disease. 
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Results and discussion
The C. elegans Genome Project [5] identified two open
reading frames, designated F02E8.6 and F09G8.4, that are
similar in sequence to the human NPC1 disease gene [2].
We subsequently named these predicted genes npc-1 and
npc-2, respectively. Through additional bioinformatic
analysis, we modified the Genome Project’s prediction of
npc-2 to incorporate additional homology found in adja-
cent sequences (see the Supplementary material). The
predicted amino acid sequences of the NPC-1 and NPC-2
proteins each have 31% identity (45% similarity) with
human NPC1 and contain all of the structural domains
Figure 1
C. elegans contains two homologs of human NPC1 protein. (a) The
alignment of the human NPC1 protein [2] and the predicted open
reading frames of the C. elegans homologs NPC-1 and NPC-2 (see
Supplementary material) are shown. The conserved domains depicted
are signal peptides (SP), NPC domains (NPC), Patched homology
regions (PTC) and sterol-sensing domains (SSD). Proteins are drawn
to the scale indicated. (b) The clustal W alignment shows strong
conservation among NPC domains. Asterisks indicate the eight
conserved cysteines that characterize the NPC domain. Boxed amino
acids are either conserved (pale shaded) or identical (dark shaded).
(c) Diagram of the npc-1 and npc-2 deletion mutations. The
npc-1(nr2022) allele contains a 1119 bp deletion and the
npc-2(nr2023) allele contains a 1796 bp deletion. The npc-1 deletion
removes nucleotides 30,646–29,528 in cosmid F02E8 (GenBank
accession number U53340) and the npc-2 deletion removes
nucleotides 6,929–8,724 in cosmid F09G8 (GenBank accession
number L11247). Filled boxes indicate predicted exons. Both
deletions are predicted to cause frameshifts followed by termination
codons close to the deletion breakpoints; exons following the
predicted termination codons are indicated by open boxes.
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identified in mammalian NPC proteins. These domains
include an amino-terminal signal peptide, an NPC
domain, a sterol-sensing domain and regions similar to the
Patched morphogen receptor (Figure 1a) [6–8]. The NPC
domain, which is unique to NPC proteins [2,9], spans
approximately 110 amino acids and is characterized by a
conserved pattern of cysteine residues (Figure 1b). The
sterol-sensing domain is found in a number of proteins
known to be responsive to intracellular sterol concentra-
tions including hydroxymethylglutaryl-CoA reductase and
SCAP (SREBP cleavage activating protein) [10,11]. 
To examine the role of NPC proteins in C. elegans, we gen-
erated deletion mutations in both npc-1 and npc-2. These
deletion mutations, npc-1(nr2022) and npc-2(nr2023), each
remove sequences near the 5¢ ends of the genes and are
predicted to cause frameshift mutations that truncate the
resulting proteins near their amino termini (Figure 1c). As
human NP-C disease is characterized by a cholesterol-traf-
ficking defect, we tested whether cholesterol metabolism
was affected in the C. elegans npc mutants. C. elegans cannot
synthesize cholesterol and requires exogenous sterol for
viability [12]. We found that newly hatched wild-type
animals grew to adulthood in the absence of cholesterol in
the growth medium, but that their progeny died as young
larvae (Table 1 and data not shown). In contrast, most
newly hatched npc-1 and npc-1; npc-2 mutant animals
grown in the absence of cholesterol died as first-stage or
second-stage larvae (Table 1). The hypersensitivity of
npc-1 mutant animals to cholesterol deprivation suggests
that the NPC-1 protein is involved in the uptake or uti-
lization of cholesterol. 
Both npc-1 single-mutant and npc-1; npc-2 double-mutant
animals had two other defects. First, these animals
developed more slowly than wild-type animals. Develop-
ment was slowed during the late stages of embryogenesis
(from the 3-fold stage to hatching) such that embryogen-
esis was lengthened by about 2.5 hours to 16.5 hours.
Development was also slowed during each of the four
larval stages such that the time required for larval devel-
opment from hatching to adulthood was lengthened by
about 24 hours. In contrast, npc-2 mutant animals did not
show growth defects during embryonic or larval develop-
ment. Because npc-1 and npc-1; npc-2 mutant animals are
hypersensitive to cholesterol deprivation, the growth
delay of these animals may reflect an underlying impair-
ment in cholesterol metabolism. 
Second, npc-1 single-mutant and npc-1; npc-2 double-
mutant animals showed hyperactive egg-laying behavior,
the so-called egg-laying constitutive (Egl-c) phenotype,
characterized by the premature expulsion of embryos from
the uterus [13–15]. We found that animals lacking npc-1
function had fewer eggs in their uteri (Figure 2a) and also
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Figure 2
The npc mutant animals lay eggs prematurely. (a) The number of eggs
per uterus was counted in each strain: npc-1 adults had only about
20–25% of the number of eggs that wild-type adults had and
npc-1; npc-2 adults had an intermediate number of eggs.
Interpretation of the double-mutant phenotype is complicated by the
poor health of these animals relative to the single mutants, which
could non-specifically interfere with egg laying and obscure an Egl-c
defect. Error bars indicate standard deviation and n = 50 for each
strain. (b) The percentage of early-stage eggs laid was determined for
each strain. No eggs from wild-type adults were laid before the
10-cell stage, whereas a significant proportion of eggs from npc-1
and npc-1; npc-2 adults were laid before this stage. A smaller
proportion of eggs were laid prematurely in npc-2 animals. Because
the rates of early embryonic development were similar for all strains
(see text), differences in the stage at which eggs were laid reflect
differences in egg-laying frequency. n ‡ 100 for each strain.
Table 1
Cholesterol sensitivity.
Strain % L3 larvae or older*
With cholesterol No cholesterol
N2 (wild type) 100 98
npc-1(nr2022) 92 14
npc-2(nr2023) 100 97
npc-1(nr2022); npc-2(nr2023) 94 17
*Newly hatched L1 larvae were placed in the presence or absence  of
cholesterol and their growth to the third larval stage (L3) or older was
monitored. For the npc-1(nr2022); npc-2(nr2023) strain, dauers were
scored instead of L3 stage larvae. n > 250 for each strain.
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laid developmentally premature eggs (Figure 2b). Although
the cause of the Egl-c phenotype of npc mutant animals is
unclear, recent molecular data showing a link between
G-protein signaling and the rate of egg laying [13–15] raise
the possibility that the npc genes are involved, directly or
indirectly, in mediating this signaling pathway. 
Unlike either npc-1 or npc-2 single-mutant animals, npc-1;
npc-2 double-mutant animals had a striking developmental
defect — inappropriate dauer larva formation. Dauer
larvae are specialized for survival under harsh environ-
mental conditions [16] and are normally formed only
under unfavorable conditions such as starvation, over-
crowding and high temperature. The npc-1; npc-2 mutant
animals inappropriately formed dauer larvae under favor-
able conditions (Table 2), the so-called dauer-constitutive
(Daf-c) phenotype. 
To confirm that all the observed phenotypes are due to
mutations in npc-1 and/or npc-2, we performed transforma-
tion rescue experiments (see Supplementary material).
The cholesterol deprivation, egg-laying and slow develop-
ment phenotypes of npc-1 single mutants can be rescued
by a wild-type copy of the gene. A wild-type copy of
either npc-1 or npc-2 can rescue the Daf-c phenotype of
double-mutant animals, confirming that mutations in both
genes are required for this phenotype. Thus, the npc-1 and
npc-2 genes act redundantly to prevent dauer larva forma-
tion under favorable growth conditions. 
The Daf-c phenotype of npc-1; npc-2 animals differs from
that of most previously described Daf-c mutants [16] in
two ways. First, npc-1; npc-2 animals form dauer larvae
only transiently, eventually recovering and growing to
adulthood; and second, the Daf-c defect of npc-1; npc-2
animals is not temperature-sensitive (Table 2). This dis-
tinctive Daf-c phenotype can also be observed by laser
ablation of the sensory neurons ADF, ASI and ASG in
wild-type animals [17], suggesting that the npc genes are
required for the normal functioning of these neurons. 
Although most studies of mammalian NPC1 protein have
focused on its role in the mobilization of cholesterol from
lysosomes, a more general function in vesicular transport
has been proposed [18]. The NPC1 protein has been local-
ized to vesicles associated with lysosomes [3] and to vesi-
cles in the perisynaptic processes of astrocytes [19]. In the
light of these results, it is noteworthy that a Daf-c pheno-
type in C. elegans can be caused by mutations in genes
implicated in the trafficking and/or release of synaptic vesi-
cles [20–22], raising the possibility that the Daf-c pheno-
type of npc-1; npc-2 animals is due to a trafficking defect. 
In summary, our results support the notion that NPC pro-
teins have an evolutionarily conserved role from nematodes
to humans in both cholesterol trafficking and nervous-
system function. The phenotypes of npc-1; npc-2 animals
are well suited to both genetic and chemical screens for
identifying suppressors that can compensate for loss of npc
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Table 2
Percentage dauer formation and recovery.
L4 or adult Dauers Dauers recovered Dead eggs Other* n
15°C
N2 (wild type) 99.2 0 – 0.2 0.5 2,973
npc-1(nr2022) 98.7 0 – 0.4 0.9 1,833
npc-2(nr2023) 98.5 0 – 0.5 1.0 2,341
npc-1(nr2022); npc-2(nr2023) 0.1 98.2 100 0.6 1.1 2,843
20°C
N2 (wild type) 99.4 0 – 0.2 0.4 2,291
npc-1(nr2022) 98.5 0 – 0.3 1.2 2,066
npc-2(nr2023) 99.1 0 – 0.2 0.7 2,723
npc-1(nr2022); npc-2(nr2023) 0 97.8 100 1.5 0.7 2,601
25°C
N2 (wild type) 99.2 0 – 0.5 0.3 3,948
npc-1(nr2022) 98.7 0 – 0.8 0.5 3,765
npc-2(nr2023) 99.1 0 – 0.6 0.3 3,512
npc-1(nr2022); npc-2(nr2023) 0.2 98.2 100 0.9 0.7 3,410
Dauer formation and recovery were monitored at three temperatures for each strain. *Non-dauer larvae that were dead or developmentally arrested.
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gene function. This model for NP-C disease may help elu-
cidate the molecular function of NPC proteins and identify
potential targets for therapeutic intervention. 
Materials and methods
Mutant isolation and genetics
The deletion mutations npc-1(nr2022) and npc-2(nr2023) were iso-
lated from a library of worms mutagenized with ethyl methanesulfonate
by a PCR-based strategy [23]. The resulting mutant animals were
back-crossed to the wild-type strain N2 six and five times, respectively.
Strains were cultured according to standard procedures [24,25] at
20°C unless otherwise indicated. 
Cholesterol deprivation assay
Eggs were isolated from gravid adults and allowed to hatch in M9
buffer [26]. 20–25 newly hatched larvae were transferred to microtiter
wells containing 50 m l S medium with or without cholesterol [27]. A
slurry of HB101 Escherichia coli (one part pellet: four parts M9) was
washed five times with M9 to remove residual cholesterol from the
medium, and 2 m l of the slurry was added to each well as a food source. 
Growth rates
To determine larval growth rates a synchronized population of newly
hatched larvae was isolated and their developmental stage was moni-
tored every 12 h (n > 200 for each strain). Embryonic growth rates
were determined by isolation of two-cell embryos and monitoring of
their development under Nomarski optics (n = 10 for each strain).
Development from the two-cell stage to the ten-cell stage was moni-
tored continuously to obtain the precise timing of cell divisions. There-
after, embryos were monitored every hour, and the timing of
developmental landmarks (comma, 1.5-fold, and 3-fold stages and
hatching) was noted. 
Dauer larva formation and recovery
To quantify dauer formation and recovery, gravid adults from each strain
were placed on seeded plates, allowed to lay eggs for about 12 h, and
then removed. Progeny were scored for dead eggs after about 24h and
for dauer larva formation after 60–70 h. Recovery from the dauer larva
stage was monitored each day thereafter. Most npc-1; npc-2 dauer
larvae recovered after 2–4 days, but some took as long as 9 days. 
Supplementary material
Supplementary material including additional methodological details is
available at http://current-biology.com/supmat/supmatin.htm.
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